Time of year, age class and body condition predict Hendra virus infection in Australian black flying foxes (Pteropus alecto).


Journal

Epidemiology and infection
ISSN: 1469-4409
Titre abrégé: Epidemiol Infect
Pays: England
ID NLM: 8703737

Informations de publication

Date de publication:
01 2019
Historique:
entrez: 1 8 2019
pubmed: 1 8 2019
medline: 3 4 2020
Statut: ppublish

Résumé

Hendra virus (HeV) continues to cause fatal infection in horses and threaten infection in close-contact humans in eastern Australia. Species of Pteropus bats (flying-foxes) are the natural reservoir of the virus. We caught and sampled flying-foxes from a multispecies roost in southeast Queensland, Australia on eight occasions between June 2013 and June 2014. The effects of sample date, species, sex, age class, body condition score (BCS), pregnancy and lactation on HeV antibody prevalence, log-transformed median fluorescent intensity (lnMFI) values and HeV RNA status were assessed using unbalanced generalised linear models. A total of 1968 flying-foxes were sampled, comprising 1012 Pteropus alecto, 742 P. poliocephalus and 214 P. scapulatus. Sample date, species and age class were each statistically associated with HeV RNA status, antibody status and lnMFI values; BCS was statistically associated with HeV RNA status and antibody status. The findings support immunologically naïve sub-adult P. alecto playing an important role in maintaining HeV infection at a population level. The biological significance of the association between BCS and HeV RNA status, and BCS and HeV antibody status, is less clear and warrants further investigation. Contrary to previous studies, we found no direct association between HeV infection and pregnancy or lactation. The findings in P. poliocephalus suggest that HeV exposure in this species may not result in systemic infection and virus excretion, or alternatively, may reflect assay cross-reactivity with another (unidentified) henipavirus.

Identifiants

pubmed: 31364577
pii: S0950268819001237
doi: 10.1017/S0950268819001237
pmc: PMC6625375
doi:

Substances chimiques

Antibodies, Viral 0
RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e240

Références

Aust Vet J. 2001 Mar;79(3):199-206
pubmed: 11301749
Microbes Infect. 2001 Apr;3(4):307-14
pubmed: 11334748
J Virol Methods. 2001 Oct;98(1):33-40
pubmed: 11543882
Vet Rec. 2004 May 22;154(21):664
pubmed: 15198316
J Virol. 2005 Jun;79(11):6690-702
pubmed: 15890907
J Virol Methods. 2007 Jun;142(1-2):29-40
pubmed: 17292974
Proc Biol Sci. 2008 Apr 7;275(1636):861-9
pubmed: 18198149
Emerg Infect Dis. 2010 Feb;16(2):219-23
pubmed: 20113550
Emerg Infect Dis. 2010 Feb;16(2):338-40
pubmed: 20113576
PLoS One. 2011;6(9):e25275
pubmed: 21980413
Am J Trop Med Hyg. 2011 Nov;85(5):946-51
pubmed: 22049055
PLoS One. 2011;6(12):e28816
pubmed: 22194920
PLoS One. 2012;7(1):e30346
pubmed: 22253928
Curr Opin Virol. 2011 Dec;1(6):658-61
pubmed: 22440924
Curr Top Microbiol Immunol. 2012;359:11-23
pubmed: 22476530
PLoS One. 2012;7(7):e40308
pubmed: 22808132
Lancet Infect Dis. 2012 Oct;12(10):799-807
pubmed: 22921953
PLoS One. 2013 Jun 27;8(6):e67584
pubmed: 23826322
J Virol Methods. 2013 Nov;193(2):295-303
pubmed: 23835034
PLoS One. 2013 Nov 28;8(11):e80430
pubmed: 24312221
Proc Biol Sci. 2014 Jul 7;281(1786):null
pubmed: 24827436
PLoS One. 2014 Jun 17;9(6):e99965
pubmed: 24936789
Proc Biol Sci. 2015 Jan 7;282(1798):20142124
pubmed: 25392474
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3302
pubmed: 25412358
PLoS One. 2015 May 04;10(5):e0125741
pubmed: 25938493
PLoS One. 2015 May 27;10(5):e0125881
pubmed: 26016629
PLoS One. 2015 Jun 10;10(6):e0128835
pubmed: 26060997
PLoS One. 2015 Oct 15;10(10):e0140670
pubmed: 26469523
PLoS One. 2015 Dec 01;10(12):e0144055
pubmed: 26625128
Ecohealth. 2016 Mar;13(1):49-59
pubmed: 27026357
Epidemiol Infect. 2016 Nov;144(15):3176-3183
pubmed: 27357144
PLoS Negl Trop Dis. 2016 Aug 04;10(8):e0004796
pubmed: 27489944
J Wildl Dis. 2017 Jan;53(1):111-120
pubmed: 27723384
Transbound Emerg Dis. 2017 Dec;64(6):1898-1911
pubmed: 28054443
BMC Vet Res. 2017 Apr 13;13(1):103
pubmed: 28407738
Sci Rep. 2017 Aug 18;7(1):8763
pubmed: 28821722
Epidemiol Infect. 2017 Nov;145(15):3143-3153
pubmed: 28942750
Sci Rep. 2018 Mar 1;8(1):3859
pubmed: 29497106
Ann N Y Acad Sci. 2018 Oct;1429(1):78-99
pubmed: 30138535
Science. 1995 Apr 7;268(5207):94-7
pubmed: 7701348
Am J Clin Nutr. 1997 Aug;66(2):464S-477S
pubmed: 9250134

Auteurs

D Edson (D)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

A J Peel (AJ)

Environmental Futures Research Institute,Griffith University,Nathan,Queensland,Australia.

L Huth (L)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

D G Mayer (DG)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

M E Vidgen (ME)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

L McMichael (L)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

A Broos (A)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

D Melville (D)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

J Kristoffersen (J)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

C de Jong (C)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

A McLaughlin (A)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

H E Field (HE)

Biosecurity Queensland,Department of Agriculture and Fisheries, Coopers Plains,Queensland,Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH